On March 26, 2009, the Patented Medicine Prices Review Board (PMPRB), Canada's federal price control body, released a revised draft Excessive Price Guidelines document for comment. This marks the latest in a series of consultation documents released by the PMPRB over the past few years as it has embarked on its plan to overhaul the Guidelines.

While comments will be received until April 27, 2009, the PMPRB has indicated that it considers the new Guidelines in nearly final form.

For more details, please see: http://www.gowlings.com/resources/enewsletters/DrugPricingReimbursement/ HtmFiles/V3N05_20090402.en.html